Sodium zirconium cyclosilicate (SZC) is a synthetic compound used to treat hyperkalemia, a condition in which the levels of potassium in the blood are too high. It works by binding to potassium in the gastrointestinal tract and preventing it from being absorbed into the bloodstream. SZC is available in both oral and intravenous formulations, and it has been approved by the U.S. Food and Drug Administration (FDA). SZC is considered a safe and effective treatment for hyperkalemia, and it is used in many hospitals and clinics around the world. It is also used in combination with other medications to treat a variety of other conditions, such as kidney disease, high blood pressure, and heart failure.
Sodium zirconium cyclosilicate (SZC), sold under the brand name Lokelma, is a medication used to treat high blood potassium levels (hyperkalemia) in adults [1, 2, 3]. Here's a closer look at its key features:
Function:
- SZC works by acting as a potassium binder in the digestive tract. It traps excess potassium ions within its structure as waste, preventing them from being absorbed into the bloodstream [1, 2]. This helps lower overall blood potassium levels.
Use in Hyperkalemia Treatment:
- SZC is effective for managing mild to moderate hyperkalemia. It's not intended for emergency treatment of life-threatening potassium imbalances because its effects take some time to kick in [2, 3].
Administration and Onset of Action:
- SZC comes as a powder packet that needs to be mixed with water and taken orally. You can take it with or without food [2, 3].
- The initial reduction in potassium levels can be seen within one to six hours of ingestion, with normal potassium levels (normokalemia) typically achieved within 24 to 48 hours [2, 3].
Advantages:
- SZC is generally well-tolerated and has a low risk of causing side effects compared to other potassium-lowering medications [2, 3].
- It does not affect the levels of other important electrolytes like calcium or magnesium [3].
Considerations:
- While uncommon, potential side effects of SZC include constipation and low blood potassium (hypokalemia) if taken for extended periods [2, 3].
- Patients with kidney problems or those on dialysis may require adjustments in dosing or frequency [3].